AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
LSE:AZN
Price:
10 694
GBX
-1.15%
Market Cap:
165.8B
GBX
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
131.1
Current
152.1
Median
12.8
Industry
Lower
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=131.1
Enterprise Value
/
1.9T GBX
EBITDA
19.9B USD
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
1.2
2-Years Forward
EV/EBITDA
1.1
3-Years Forward
EV/EBITDA
1
You don't have any saved screeners yet
